Mineralocorticoid Receptor Antagonists in High-Risk Heart Failure Patients With Diabetes Mellitus and/or Chronic Kidney Disease

被引：6
作者：
Pitt, Bertram [1 ]
Rossignol, Patrick [2 ,3 ]
机构：
[1] Univ Michigan, Sch Med, 1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA
[2] Univ Lorraine, CHRU Nancy, Inserm U1116, Ctr Invest Clin Plurithemat 14 33, Nancy, France
[3] F CRIN INI CRCT Cardiovasc & Renal Clin Trialists, Nancy, France
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2017年 / 6卷 / 12期
关键词：
Editorials; chronic kidney disease; diabetes mellitus; heart failure; hyperkalemia; outcomes research; WORSENING RENAL-FUNCTION; MILD PATIENTS HOSPITALIZATION; SPIRONOLACTONE; HYPERKALEMIA; EPLERENONE; GUIDELINES; SURVIVAL; THERAPY;
D O I：
10.1161/JAHA.117.008054
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 18 条
[1]   Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease [J].
Cooper, Lauren B. ;
Lippmann, Steven J. ;
Greiner, Melissa A. ;
Sharma, Abhinav ;
Kelly, Jacob P. ;
Fonarow, Gregg C. ;
Yancy, Clyde W. ;
Heidenreich, Paul A. ;
Hernandez, Adrian F. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (12)
[2]   Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure [J].
Cooper, Lauren B. ;
Hammill, Bradley G. ;
Peterson, Eric D. ;
Pitt, Bertram ;
Maciejewski, Matthew L. ;
Curtis, Lesley H. ;
Hernandez, Adrian F. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (18) :1973-1975
[3]   Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation [J].
de Denus, Simon ;
O'Meara, Eileen ;
Desai, Akshay S. ;
Claggett, Brian ;
Lewis, Eldrin F. ;
Leclair, Gregoire ;
Jutras, Martin ;
Lavoie, Joel ;
Solomon, Scott D. ;
Pitt, Bertram ;
Pfeffer, Marc A. ;
Rouleau, Jean L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17) :1690-1692
[4]   Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function Analyses of the EMPHASIS-HF Study Subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) [J].
Eschalier, Romain ;
McMurray, John J. V. ;
Swedberg, Karl ;
van Veldhuisen, Dirk J. ;
Krum, Henry ;
Pocock, Stuart J. ;
Shi, Harry ;
Vincent, John ;
Rossignol, Patrick ;
Zannad, Faiez ;
Pitt, Bertram .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (17) :1585-1593
[5]   Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions [J].
Lund L.H. ;
Oldgren J. ;
James S. .
Current Heart Failure Reports, 2017, 14 (2) :59-70
[6]   Association of Spironolactone Use With All-Cause Mortality in Heart Failure A Propensity Scored Cohort Study [J].
Lund, Lars H. ;
Svennblad, Bodil ;
Melhus, Hakan ;
Hallberg, Par ;
Dahlstrom, Ulf ;
Edner, Magnus .
CIRCULATION-HEART FAILURE, 2013, 6 (02) :174-+
[7]   Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry [J].
Maggioni, Aldo P. ;
Anker, Stefan D. ;
Dahlstrom, Ulf ;
Filippatos, Gerasimos ;
Ponikowski, Piotr ;
Zannad, Faiez ;
Amir, Offer ;
Chioncel, Ovidiu ;
Leiro, Marisa Crespo ;
Drozdz, Jaroslaw ;
Erglis, Andrejs ;
Fazlibegovic, Emir ;
Fonseca, Candida ;
Fruhwald, Friedrich ;
Gatzov, Plamen ;
Goncalvesova, Eva ;
Hassanein, Mahmoud ;
Hradec, Jaromir ;
Kavoliuniene, Ausra ;
Lainscak, Mitja ;
Logeart, Damien ;
Merkely, Bela ;
Metra, Marco ;
Persson, Hans ;
Seferovic, Petar ;
Temizhan, Ahmet ;
Tousoulis, Dimitris ;
Tavazzi, Luigi .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (10) :1173-1184
[8]   Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction [J].
Pitt, B. ;
Rossignol, P. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (03) :389-391
[9]   Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia [J].
Pitt, Bertram ;
Rossignol, Patrick .
PHARMACOLOGICAL RESEARCH, 2017, 118 :2-4
[10]   The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure [J].
Pitt, Bertram ;
Rossignol, Patrick .
EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) :659-665
12